产品
编 号：F063154
分子式：C26H28N6O5S
分子量：536.6
分子式：C26H28N6O5S
分子量：536.6
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
CAS No: 1188371-47-2
产品详情
生物活性：
Valecobulin (CKD516) is a valine proagent of (S516) and a vascular disrupting agent (VDA). Valecobulin is a potent β-tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.
体内研究：
Valecobulin (5 mg/kg; intraperitoneal injection; administered on days 2, 6, 10, and 14; male BALB/C nu/nu mice) treatment shows markedly antitumor efficacy in various human tumor xenograft models.Animal Model:Male BALB/C nu/nu mice (5-6 weeks of age) with HCT-116 or HCT-15 cells
Dosage:5 mg/kg
Administration:Intraperitoneal injection; administered on days 2, 6, 10, and 14
Result:Had shown marked antitumor efficacy in various human tumor xenograft models.
Valecobulin (CKD516) is a valine proagent of (S516) and a vascular disrupting agent (VDA). Valecobulin is a potent β-tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.
体内研究：
Valecobulin (5 mg/kg; intraperitoneal injection; administered on days 2, 6, 10, and 14; male BALB/C nu/nu mice) treatment shows markedly antitumor efficacy in various human tumor xenograft models.Animal Model:Male BALB/C nu/nu mice (5-6 weeks of age) with HCT-116 or HCT-15 cells
Dosage:5 mg/kg
Administration:Intraperitoneal injection; administered on days 2, 6, 10, and 14
Result:Had shown marked antitumor efficacy in various human tumor xenograft models.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备